Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Dose Ascending, Randomized, Placebo-Controlled Clinical Trial to Assess Tolerability and Pharmacokinetics of ApTOLL in Healthy Volunteers

NCT04742062 is registered in ClinicalTrials.gov with aptaTargets S.L. as lead sponsor.

NCT NCT04742062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04742062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Dose Ascending, Randomized, Placebo-Controlled Clinical Trial to Assess Tolerability and Pharmacokinetics of ApTOLL in Healthy Volunteers
Lead sponsor
aptaTargets S.L.
Phase
Phase 1
Overall status
Completed
Start date
July 18, 2019
Completion date
March 20, 2020
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke